Skip to main content
Premium Trial:

Request an Annual Quote

Ned Barnholt, William Sullivan, James Cullen, Samraat Raha, Robert Lefebvre, Macdonald Morris, Erkki Ruoslahti, Masatoshi Takeichi, Alan Hall, Svante Pbo, and Ludwig Tern

Agilent chairman, president and CEO Ned Barnholt will retire at the end of next month, the Palo Alto, Calif.-based firm announced Wednesday.

Barnholt, who has served as CEO for the past six years, will be succeeded by William Sullivan, who currently serves as executive vice president and COO. Sullivan also oversees Agilent's largest business, the Electronic Products and Solutions Group.

James Cullen, who has served on Agilent's board of directors since 2000, will take over as non-executive chairman upon Barnholt's departure.

Samraat Raha, former vice president of GE Healthcare’s CodeLink microarray product line, has joined Agilent Technologies’ Life Science and Chemical Analysis business unit as vice president of field operations for the Americas, BioCommerce Week has learned. He reports to Lon Justice, VP and general manager of worldwide sales, marketing and services. Raha manages sales and marketing for the Americas, including all LSCA markets (Integrated Biology, Pharmaceutical Analysis, Chemical Analysis, Consumables & Services). Raha joined Amersham before the company’s acquisition by General Electric and worked there for almost two years before joining Agilent. Previously, he was chief business officer for EraGen of Madison, Wis., and prior to that, he was vice president of discovery services and bioreagents for Incyte Genomics.

Robert Lefebvre has been promoted to vice president of global marketing for MDS Pharma Services, a unit of MDS, which is a partner of Applied Biosystems. Lefebvre will be based at the company’s King of Prussia, Pa., offices. Lefebvre previously was vice president and brand manager for oncology global marketing for Bristol-Myers Squibb.

Macdonald Morris, lead scientist and then senior scientist at Affymetrix from 1993 to 1998, joined Lipomics Technologies of West Sacramento, Calif., as chief technology officer and vice president of bioinformatics, the company said this week. Morris worked at Incyte Genomics of Palo Alto from 1998 to 2002 as associate director, director and then senior director of bioinformatics, then joined Expression Diagnostics of South San Francisco as vice president of informatics, where he worked to define the company’s informatics strategy and R&D plans.

Erkki Ruoslahti of the Burnham Institute and Masatoshi Takeichi of the Riken Center for Developmental Biology in Kobe, Japan, have been named as winners of the 2006 Japan Prize in cell biology and will share the prize of $487,000 presented by the Science and Technology Foundation of Japan.

Alan Hall, director of the Medical Research Council of London, and Svante Pääbo of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, were named as 2005 winners of the Louis-Jeantet-Prize for Medicine awarded by the Geneva-based Louis-Jeantet Foundation for Medicine and offered to help fund research projects that the prize-winners’ institutions would not be able to fund in their entirety, the foundation said in a statement. The winners will share funding of €800,000 and will receive a personal prize of €75,000.

Ludwig Terán was named vice president of sales and marketing for SecureSpeed of Chino Hills, Calif., the company said last week. He has previously worked in sales, management and marketing with Amersham, Whatman, and Thermo Electron.


The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.